Visionary investment in mRNA technology platforms is allowing ST PHARM and its two startups, Levatio Therapeutics and ...

HSINCHU, Dec. 2, 2025 /PRNewswire/ -- Amaran Biotech, a next-generation Contract Development and Manufacturing Organization (CDMO), announced that its self-developed, GMP-grade high-purity vaccine ...

Five-year exclusive distribution agreement builds foundation for niche vaccines and future collaboration in Malaysia -- ...

In the early 2000s, immunologist Bali Pulendran started his lab at Emory University to explore the mechanisms underlying vaccine-mediated immunity. To uncover these processes, he focused on the yellow ...

GPN Vaccines, a clinical-stage biotechnology company developing broadly protective bacterial vaccines, has closed a fully subscribed $10 million private placement with participation from new and ...

Hyderabad-based PopVax unveils RNA Foundry to produce personalised mRNA cancer vaccines for patients.

DNA vaccines represent a versatile platform in which plasmid DNA encoding the SARS-CoV-2 spike antigen is delivered into host cells to elicit both antibody-mediated and T cell-mediated immunity. Rapid ...

An optimized 14-L fermentation process for Streptococcus suis serotype 31 achieved 1.51 × 10¹⁰ CFU/mL and produced an ...

QUEBEC CITY, Feb. 17 /CNW/ - Medicago Inc. (TSX-V: MDG), a clinical-stage biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing ...

Vaxcyte remains in focus after recent clinical and pipeline updates around its pneumococcal vaccine program, a key catalyst for a US-listed biotech tied to respiratory disease prevention. PCVX, ...

Bharat Biotech cuts malaria vaccine price by ~40% to €5.50 per dose via Gavi-UNICEF pact backed by IFFIm funding.

Hyderabad-based Bharat Biotech has announced a 40% price reduction for its Mosqivac malaria vaccine, aiming to expand immunization access for children in high-burden regions starting in 2027.